Engineers Gate Manager LP Amicus Therapeutics, Inc. Transaction History

Engineers Gate Manager LP

$4.86 Billion
Q3 2024

A detailed history of Engineers Gate Manager LP transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 150,722 shares of FOLD stock, worth $1.45 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

150,722

Previous 38,737 289.09%

Holding current value

$1.45 Million

Previous $384,000 319.01%

% of portfolio

0.03%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$9.55 - $12.09 $1.07 Million - $1.35 Million	111,985 Added 289.09%	150,722 $1.61 Million
Q2 2024 Aug 14, 2024	SELL	$9.04 - $11.75 $495,364 - $643,864	-54,797 Reduced 58.59%	38,737 $384,000
Q1 2024 May 15, 2024	BUY	$11.43 - $14.24 $757,260 - $943,428	66,252 Added 242.84%	93,534 $1.1 Million
Q4 2023 Feb 14, 2024	BUY	$9.97 - $14.52 $67,447 - $98,227	6,765 Added 32.97%	27,282 $387,000
Q3 2023 Nov 14, 2023	SELL	$11.78 - $13.86 $643,435 - $757,047	-54,621 Reduced 72.69%	20,517 $249,000
Q2 2023 Aug 14, 2023	BUY	$10.72 - $13.3 $567,795 - $704,447	52,966 Added 238.89%	75,138 $943,000
Q1 2023 May 15, 2023	BUY	$10.91 - $13.54 $45,811 - $56,854	4,199 Added 23.36%	22,172 $245,000
Q4 2022 Feb 14, 2023	BUY	$9.89 - $12.7 $77,676 - $99,745	7,854 Added 77.62%	17,973 $219,000
Q3 2022 Nov 14, 2022	BUY	$9.82 - $12.75 $99,368 - $129,017	10,119 New	10,119 $106,000
Q2 2022 Aug 15, 2022	SELL	$6.23 - $11.12 $126,911 - $226,525	-20,371 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$7.89 - $12.48 $160,727 - $254,230	20,371 New	20,371 $193,000
Q4 2021 Feb 14, 2022	SELL	$9.82 - $12.44 $230,436 - $291,917	-23,466 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$8.74 - $11.84 $717,370 - $971,815	-82,079 Reduced 77.77%	23,466 $224,000
Q2 2021 Aug 16, 2021	BUY	$8.71 - $10.72 $736,386 - $906,322	84,545 Added 402.6%	105,545 $1.02 Million
Q1 2021 May 17, 2021	BUY	$9.2 - $23.86 $4,176 - $10,832	454 Added 2.21%	21,000 $207,000
Q4 2020 Feb 16, 2021	SELL	$13.47 - $24.89 $650,466 - $1.2 Million	-48,290 Reduced 70.15%	20,546 $474,000
Q3 2020 Nov 16, 2020	BUY	$12.89 - $15.89 $711,244 - $876,778	55,178 Added 404.0%	68,836 $972,000
Q2 2020 Aug 17, 2020	BUY	$8.86 - $15.69 $121,009 - $214,294	13,658 New	13,658 $206,000
Q1 2020 May 15, 2020	SELL	$6.63 - $11.16 $651,046 - $1.1 Million	-98,197 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$7.48 - $10.75 $644,753 - $926,617	86,197 Added 718.31%	98,197 $956,000
Q3 2019 Nov 14, 2019	BUY	$8.02 - $13.25 $96,240 - $159,000	12,000 New	12,000 $96,000
Q2 2019 Aug 14, 2019	SELL	$10.96 - $14.4 $250,984 - $329,760	-22,900 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$10.04 - $13.92 $229,915 - $318,768	22,900 New	22,900 $311,000
Q4 2017 Feb 01, 2018	SELL	$12.51 - $16.24 $128,853 - $167,271	-10,300 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$11.74 - $15.78 $120,922 - $162,534	10,300	10,300 $155,000

Others Institutions Holding FOLD

# of Institutions

312

Shares Held

312M

Call Options Held

516K

Put Options Held

833K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.69B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Account

Engineers Gate Manager LP Amicus Therapeutics, Inc. Transaction History